Menopause brain fog may have met a contender: a PQQ, GABA, caffeine and B-vitamin combo that beat placebo in a 6-week randomized trial. In 63 healthy postmenopausal women, it lifted the global Neurocognition Index by 5.89 points, plus memory (+7.86), visual memory and cognitive flexibility. But one attention measure went the opposite way, and executive functioning only trended. The trial is small, short and tests a combo product, so no single ingredient gets the credit. Here is what the numbers show, who might care, and who should skip it.
This page is available in